CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p

被引:0
作者
Mei Zheng
Lingli Xu
Cuifeng Wei
Wenzhen Guan
机构
[1] The First People’s Hospital of Jingmen City,Department of Endocrinology
来源
Hormones | 2023年 / 22卷
关键词
PTC; circRTN1; miR-101-3p; HMGB1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 293
页数:12
相关论文
共 208 条
  • [1] Goncalves CFL(2017)Flavonoids, thyroid iodide uptake and thyroid cancer-a review Int J Mol Sci. 18 1247-188
  • [2] de Freitas ML(2019)Multikinase inhibitor treatment in thyroid cancer Int J Mol Sci. 21 10-2795
  • [3] Ferreira ACF(2021)Current practice in patients with differentiated thyroid cancer Nat Rev Endocrinol. 17 176-78
  • [4] Ancker OV(2016)Thyroid cancer Lancet. 388 2783-331
  • [5] Kruger M(2020)Therapeutic breakthroughs for metastatic thyroid cancer Nat Rev Endocrinol. 16 77-472
  • [6] Wehland M(2017)Epigenetic modifications: novel therapeutic approach for thyroid cancer Endocrinol Metab (Seoul). 32 326-2768
  • [7] Infanger M(2018)Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis Cancer Manag Res. 10 465-930
  • [8] Grimm D(2021)Clinicopathological Significance of papillary thyroid carcinoma located in the isthmus: a meta-analysis World J Surg. 45 2759-691
  • [9] Schlumberger M(2021)Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: a single-center observational study in Taiwan Biomed J. 45 923-1353
  • [10] Leboulleux S(2021)Complement C4-A and plasminogen as potential biomarkers for prediction of papillary thyroid carcinoma Front Endocrinol (Lausanne). 12 737638-944